Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Eva Rye Rasmussen"'
Publikováno v:
Archives of Clinical and Experimental Surgery, Vol 6, Iss 3, Pp 120-125 (2017)
Objective: Ketorolac is a non-steroid anti-inflammatory drug for intravenous use, with analgesic and anti-inflammatory effects and known for its potent influence on moderate to severe postoperative pain. The literature has shown that 30mg i.v. periop
Externí odkaz:
https://doaj.org/article/275356b704244595b41ff159db3d6c60
Autor:
Haivin Aziz Ali, Anne Fog Lomholt, Seyed Hamidreza Mahmoudpour, Thorbjørn Hermanrud, Anette Bygum, Christian von Buchwald, Marianne Antonius Jakobsen, Eva Rye Rasmussen
Publikováno v:
PLoS ONE, Vol 14, Iss 12, p e0227056 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0224858.].
Externí odkaz:
https://doaj.org/article/11550a5fcebb48c6a4afaaa687e2e620
Autor:
Haivin Aziz Ali, Anne Fog Lomholt, Seyed Hamidreza Mahmoudpour, Thorbjørn Hermanrud, Anette Bygum, Christian von Buchwald, Marianne Antonius Jakobsen, Eva Rye Rasmussen
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224858 (2019)
Angiotensin-converting enzyme (ACE) converts angiotensin I to angiotensin II which causes vasoconstriction. ACE inhibitors reduce blood pressure by inhibiting ACE. A well-known adverse drug reaction to ACE inhibitors is ACE inhibitor-induced angioede
Externí odkaz:
https://doaj.org/article/1837de91b9dc41d19524a20c8ed8f27d
Autor:
Eva Rye Rasmussen, Christian von Buchwald, Mia Wadelius, Sumangali Chandra Prasad, Shailajah Kamaleswaran, Kawa Khaled Ajgeiy, Georg Authried, Kristine Appel U. Pallesen, Anette Bygum
Publikováno v:
International Journal of Otolaryngology, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/6f535a437f0f44afbb1521a50d89487e
Autor:
Eva Rye Rasmussen, Christian von Buchwald, Mia Wadelius, Sumangali Chandra Prasad, Shailajah Kamaleswaran, Kawa Khaled Ajgeiy, Georg Authried, Kristine Appel U. Pallesen, Anette Bygum
Publikováno v:
International Journal of Otolaryngology, Vol 2017 (2017)
Objective. To asses a cohort of 105 consecutive patients with angiotensin converting enzyme-inhibitor induced angioedema with regard to demographics, risk factors, family history of angioedema, hospitalization, airway management, outcome, and use of
Externí odkaz:
https://doaj.org/article/b69d258768b6469c9c9511e9d3ac27cc
Publikováno v:
Case Reports in Emergency Medicine, Vol 2016 (2016)
Angioedema of the upper airways is a severe and potentially life-threatening condition. The incidence has been increasing in the past two decades, primarily due to pharmaceuticals influencing the generation or degradation of the vasoactive molecule b
Externí odkaz:
https://doaj.org/article/ad64d321970e4891b1cb4bc0e7fc9705
Publikováno v:
Ear and hearing.
This study investigated age at implantation, improvement in hearing and speech perception outcomes, as well as surgical complications in pediatric cochlear implant recipients with Pendred Syndrome (PS) or non-syndromic enlarged vestibular aqueduct (N
Autor:
Gustav Ahlberg, Henrik Ullum, Oscar Petersen, Eva Rye Rasmussen, Michael Schwinn, Karina Banasik, Erik Sørensen, Morten S. Olesen, Søren Brunak, Mia Wadelius, Ina Holst Larsen, Niclas Eriksson, Pär Hallberg, Henning Bundgaard, Laura Andreasen, Jonas Ghouse
Publikováno v:
Journal of the American College of Cardiology. 78:696-709
Background Angioedema is a rare but potentially life-threatening adverse reaction associated with angiotensin-converting enzyme (ACE) inhibitors. Identification of potential genetic factor...
Publikováno v:
Drug, Healthcare and Patient Safety. 11:105-113
Purpose The primary objective of this study was to calculate the report rate of angiotensin-converting enzyme inhibitor-related angioedema (ACEi-AE). Secondary objectives were to determine factors suspected to affect the likelihood of ACEi-AE being r
Publikováno v:
Pharmacogenomics. 22(6)